alexa Tolerance of TS-1 a Monotherapy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Tolerance of TS-1 a Monotherapy

Thymic cancer is a rare and invasive mediastinal neoplasm.Systemic chemotherapy is an important therapeutic modality for unresectable thymic cancer. However, the treatment options are extremely limited due to the lack of evidence on effective treatments,even in the first-line setting. In addition, several serious side effects of the chemotherapy may significantly restrict its efficacy.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger